Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2026-08-10 21:38:03 ET · period of report 2026-08-06 · accession 0001193125-26-343079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 21:38 | 2026-08-06 | APVO | Lamothe Jeffrey G. | Pres, CEO, Dir | M - OptEx | — | +961 | 961 | New | — |
| D | 2026-08-10 21:38 | 2026-08-06 | APVO | Lamothe Jeffrey G. | Pres, CEO, Dir | M - OptEx | $0.00 | -961 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-06 | M | A | 961 | — | 961 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2026-08-06 | M | D | 961 | $0.00 | 0 | D | — · — to — | 961 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On August 6, 2025, the reporting person was granted 17,300 (961 post-split) RSUs, vesting on the first anniversary of the date of grant. (F2) On August 6, 2025, the reporting person was granted 17,300 (961 post-split) RSUs, vesting on the first anniversary of the date of grant. |